XML 123 R74.htm IDEA: XBRL DOCUMENT v2.4.0.6
EARNINGS PER SHARE (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Earnings Per Share [Abstract]                      
Income from Continuing Operations Attributable to BMS $ 852 $ 969 $ 902 $ 986 $ 483 $ 949 $ 927 $ 743 $ 3,709 $ 3,102 $ 3,239
Earnings attributable to unvested restricted shares                 (8) (12) (18)
Income from Continuing Operations Attributable to BMS common shareholders                 3,701 3,090 3,221
Net Earnings Attributable to BMS common shareholders                 3,701 3,090 10,552
Average Common Shares Outstanding                 1,700 1,713 1,974
Basic Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company                 $ 2.18 $ 1.80 $ 1.63
Basis Earnings Per Common Share from Discontinued Operations Attributable to Bristol-Myers Squibb Company                 $ 0 $ 0 $ 3.72
Basic Earnings Per Common Share Attributable to Bristol-Myers Squibb Company $ 0.50 $ 0.57 $ 0.53 $ 0.58 $ 0.28 $ 0.55 $ 0.54 $ 0.43 $ 2.18 $ 1.80 $ 5.35
Earnings attributable to unvested restricted shares to be used in diluted calculation                 (8) (12) (17)
Income from Continuing Operations Attributable to BMS common shareholders - Diluted                 3,701 3,090 3,222
EPS Numerator - Diluted                 3,701 3,090 10,553
Contingently convertible debt common stock equivalents                 1 1 1
Incremental shares attributable to share-based compensation plans                 16 13 3
Weighted-average common shares outstanding - diluted                 1,717 1,727 1,978
Diluted Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company                 $ 2.16 $ 1.79 $ 1.63
Diluted Earnings per Common Share from Discontinued Operations Attributable to Bristol-Myers Squibb Company                     $ 3.71
Diluted Earnings per Common Share Attributable to Bristol-Myers Squibb Company $ 0.50 $ 0.56 $ 0.52 $ 0.57 $ 0.28 $ 0.55 $ 0.53 $ 0.43 $ 2.16 $ 1.79 $ 5.34
Net Earnings from Discontinued Operations Attributable to BMS                     7,373
Earnings from discontinued operations attributable to unvested restricted shares                     (42)
Net Earnings from Discontinued Operations Attributable to BMS used for EPS calculation                     $ 7,331
Anti-dilutive weighted-average equivalent shares - stock incentive plans                 13 51 117